Publications

Publications

Article
Ishiguro C*, Morita H, Mimura W, Tsuzuki S, Hirashima J, Takeuchi Y, Oda F, Maeda M, Fukuda H.
Safety monitoring of Bivalent, Quadrivalent, and 9-valent Human Papillomavirus Vaccination in Japan: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) Study.
Human Vaccines & Immunotherapeutics 2026; in press.
Maeda H*, Toizumi M, Igarashi A, Maeda M, Oda F, Fukuda H.
Incidence of COVID-19-associated Hospitalization by Vaccination Status in Children and Adolescents during Omicron-dominant Period in Japan: The VENUS Study.
Children 2026: 13: 183.
Graphical Abstract
Katsuta T*, Sato S, Kawazoe Y, Fukuda H.
Active vaccine safety monitoring system using health insurance claims data in Japan: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
Vaccine 2026; 74: 128209.
Graphical Abstract
Kawazoe Y*, Katsuta T, Tanaka T, Nakamura Y, Sato S, Maeda M, Oda F, Fukuda H.
Prevalence of HPV Vaccine–Associated Symptoms in Unvaccinated Japanese Adolescents: A Descriptive Study from the VENUS Study Database.
Vaccine 2026; 70: 128020.
Graphical Abstract
Sazawa M, Ishiguro C, Mimura W, Maeda M, Murata F, Fukuda H.
Impact of the resumption of proactive recommendation of HPV vaccination on HPV vaccination rates in Japan: An interrupted time series analysis based on the VENUS Study.
BMJ Public Health 2025; 3: e000982.
Graphical Abstract
Ishiguro C*, Mimura W, Oda F, Maeda M, Fukuda H.
Population-Based Cohort Study Assessing the Effectiveness of Maternal BNT162b2/mRNA-1273 Vaccination Against Infant Coronavirus Disease 2019 Outcomes During Omicron Predominance: The VENUS Study .
Human Vaccines & Immunotherapeutics 2025; 21(1): 2585595.
Graphical Abstract
Maeda M, Murata F, Fukuda H.
Effects of the introduction of a routine rotavirus vaccination program on vaccination coverage and factors in a Japanese municipality: The VENUS Study.
BMJ Public Health2025; 3: e002149.
Graphical Abstract
Murata F, Maeda M, Fukuda H*.
Claims-based analysis of zoster vaccine effectiveness against incident herpes zoster: The VENUS Study.
JMA Journal 2025; 8(4): 1399-1402.
Graphical Abstract
Sato S, Kawazoe Y, Murata F, Maeda M, Fukuda H.
Estimation of the adjusted risk difference for very rare events, large samples, and extreme exposure frequency: Application of Vaccine Effectiveness, Networking, and Universal Safety study.
Annals of Clinical Epidemiology2025; 7(2): 50-60.
Graphical Abstract
Kim S, Maeda M, Murata F, Fukuda H*.
Effect of COVID-19 vaccination on the risk of developing post-COVID conditions: the VENUS study.
Vaccine 2024; 43(Pt 2): 126497.
Graphical Abstract
1 2 3 4
× Graphical Abstract